PBYI

Puma Biotechnology, Inc. is a Los Angeles-based biopharmaceutical company focused on the development and commercialization of groundbreaking cancer therapies designed to improve patient outcomes globally. Leveraging precision medicine, Puma is advancing an innovative pipeline of proprietary drug candidates that target specific oncological conditions, thereby addressing significant unmet needs in the oncology market. With a robust commitment to research and development, the company is strategically positioned to be a prominent player in the dynamic cancer therapeutics landscape, offering a compelling investment opportunity for institutional investors seeking to engage with transformative advancements in healthcare.